Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
Cancer Research
|
December 1, 1990
Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy
R Andreesen, C Scheibenbogen, W Brugger, et al.
Cancer Research
|
September 18, 2001
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes
P Brossart, A Schneider, P Dill, et al.
Blood
|
April 21, 2001
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells
M Seiffert, P Brossart, C Cant, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 30, 1984
[Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]
G Dölken, M Bitzer, K J Bross, et al.
Cancer Detection and Prevention
|
January 1, 1991
A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes
R Andreesen, C Scheibenbogen, W Brugger, et al.
Blood
|
November 26, 1999
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47
M Seiffert, C Cant, Z Chen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 28, 2021
A higher burden of multiple sclerosis genetic risk confers an earlier onset
Elina Misicka, Mary F Davis, Woori Kim, et al.
Experimental Hematology
|
April 27, 2000
Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells
S Scheding, B Meister, H J Bühring, et al.
Critical Reviews in Oncology/Hematology
|
February 24, 2007
Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial
G Romieu, M Clemens, R Mahlberg, et al.
European Journal of Immunology
|
March 1, 1996
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients
P Fisch, G Köhler, A Garbe, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
Cancer Research
|
December 1, 1990
Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy
R Andreesen, C Scheibenbogen, W Brugger, et al.
Cancer Research
|
September 18, 2001
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes
P Brossart, A Schneider, P Dill, et al.
Blood
|
April 21, 2001
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells
M Seiffert, P Brossart, C Cant, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 30, 1984
[Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]
G Dölken, M Bitzer, K J Bross, et al.
Cancer Detection and Prevention
|
January 1, 1991
A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes
R Andreesen, C Scheibenbogen, W Brugger, et al.
Blood
|
November 26, 1999
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47
M Seiffert, C Cant, Z Chen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 28, 2021
A higher burden of multiple sclerosis genetic risk confers an earlier onset
Elina Misicka, Mary F Davis, Woori Kim, et al.
Experimental Hematology
|
April 27, 2000
Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells
S Scheding, B Meister, H J Bühring, et al.
Critical Reviews in Oncology/Hematology
|
February 24, 2007
Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial
G Romieu, M Clemens, R Mahlberg, et al.
European Journal of Immunology
|
March 1, 1996
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients
P Fisch, G Köhler, A Garbe, et al.
Page
of 12